Factors affecting the outcomes in stable chronic obstructive pulmonary disease patients at an Army Central Hospital

被引:0
作者
Nurwulandari, Nunik U. [1 ]
Zazuli, Zulfan [1 ]
Wihastuti, Retno [2 ]
Wikaningtyas, Pratiwi [1 ]
机构
[1] Bandung Inst Technol, Sch Pharm, Dept Pharmacol Clin Pharm, Bandung 40132, Indonesia
[2] Gatot Soebroto Army Cent Hosp, Dept Pulmonol, Jakarta, Indonesia
来源
PHARMACY PRACTICE-GRANADA | 2024年 / 22卷 / 01期
关键词
COPD; clinical outcomes; factors; therapeutic outcomes; LUNG-FUNCTION; RISK-FACTORS; ALCOHOL-CONSUMPTION; COPD; BURDEN; COMORBIDITIES; TUBERCULOSIS; PREVALENCE; MANAGEMENT; SYMPTOMS;
D O I
10.18549/PharmPract.2024.1.2903
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Of the four Asian countries, Indonesian COPD patients have the worst clinical features, which puts them at a high risk for treatment failure. There are a number of variables and patient traits that influence clinical results as a predictor of therapy outcomes. Objective: to identify the contributing components and how much they influence COPD patients' therapy results. Methods: This cross-sectional descriptive-observational study at a tertiary army hospital involved 74 patients. A questionnaire and medical records were utilized to obtain sociodemographic characteristics and clinical data. Correlation and logistic regression analysis were conducted to identify significant factors. Results: The results showed that tumor/cancer comorbidities affected the worsening of CAT values (OR=10.89, 95%CI=1.01-117.23, p=0.049), use of ICS/LABA drugs affected the improvement of mMRC values (OR= 0.26, 95%CI=0.08-0.84, p=0.024), history of TBC disease affected the increase in exacerbation severity (OR=7.25, 95%CI=1.05-50.23, p=0.045), age from smoking >20 years affected the reduction in exacerbation severity (OR=0.03, 95%CI=0.002-0.61, p=0.022). History of alcohol use (OR=7.26 and 167.56, p=0.014 and 0.004) and comorbid pneumonia (OR=28.14 and 44.25, p=0.035 and 0.014) contributed to an increase in the frequency of exacerbations and hospitalization per year. Medium economic status affects the decrease in hospitalizations per year (OR=0.06, 95%CI=0.00-0.91, p=0.043) while the diagnosis of severe COPD and history of alcohol affected the decrease in COPD severity (ABCD) (OR=0.12 and 0.24, p=0.039 and 0.009). Conclusion: comorbidities, disease history, history of alcohol use, COPD status and the use of COPD medications contributed to variations therapeutic outcomes COPD patients. Therefore, it must be taken into account when making clinical decisions.
引用
收藏
页数:16
相关论文
共 61 条
  • [51] The COPD (Chronic Obstructive Pulmonary Disease) Assessment Test: Assessment of Therapeutic Outcomes of Patients at Private Hospitals in Yogyakarta
    Sari, Chynthia Pradiftha
    Hanifah, Suci
    Rosdiana, Rosdiana
    Anisa, Yuni
    [J]. JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2020, 12 : 821 - 825
  • [52] Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample
    Shahab, L.
    Jarvis, M. J.
    Britton, J.
    West, R.
    [J]. THORAX, 2006, 61 (12) : 1043 - 1047
  • [53] Guideline adherence in management of stable chronic obstructive pulmonary disease
    Sharif, Roozbeh
    Cuevas, Christel R.
    Wang, Yue
    Arora, Mohit
    Sharma, Gulshan
    [J]. RESPIRATORY MEDICINE, 2013, 107 (07) : 1046 - 1052
  • [54] Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA
    Shidara, Kumi
    Hoshi, Daisuke
    Inoue, Eisuke
    Yamada, Toru
    Nakajima, Ayako
    Taniguchi, Atsuo
    Hara, Masako
    Momohara, Shigeki
    Kamatani, Naoyuki
    Yamanaka, Hisashi
    [J]. MODERN RHEUMATOLOGY, 2010, 20 (03) : 280 - 286
  • [55] Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis
    Shuai, Tiankui
    Zhang, Chuchu
    Zhang, Meng
    Wang, Yalei
    Xiong, Huaiyu
    Huang, Qiangru
    Liu, Jian
    [J]. PLOS ONE, 2021, 16 (05):
  • [56] Drug-Induced Interstitial Lung Disease: A Systematic Review
    Skeoch, Sarah
    Weatherley, Nicholas
    Swift, Andrew J.
    Oldroyd, Alexander
    Johns, Christopher
    Hayton, Conal
    Giollo, Alessandro
    Wild, James M.
    Waterton, John C.
    Buch, Maya
    Linton, Kim
    Bruce, Ian N.
    Leonard, Colm
    Bianchi, Stephen
    Chaudhuri, Nazia
    [J]. JOURNAL OF CLINICAL MEDICINE, 2018, 7 (10):
  • [57] Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
    Soriano, Joan B.
    Abajobir, Amanuel Alemu
    Abate, Kalkidan Hassen
    Abera, Semaw Ferede
    Agrawal, Anurag
    Ahmed, Muktar Beshir
    Aichour, Amani Nidhal
    Aichour, Ibtihel
    Aichour, Miloud Taki Eddine
    Alam, Khurshid
    Alam, Noore
    Alkaabi, Juma M.
    Al-Maskari, Fatma
    Alvis-Guzman, Nelson
    Amberbir, Alemayehu
    Amoako, Yaw Ampem
    Ansha, Mustafa Geleto
    Anto, Josep M.
    Asayesh, Hamid
    Atey, Tesfay Mehari
    Avokpaho, Euripide Frinel G. Arthur
    Barac, Aleksandra
    Basu, Sanjay
    Bedi, Neeraj
    Bensenor, Isabela M.
    Berhane, Adugnaw
    Beyene, Addisu Shunu
    Bhutta, Zulfiqar A.
    Biryukov, Stan
    Boneya, Dube Jara
    Brauer, Michael
    Carpenter, David O.
    Casey, Daniel
    Christopher, Devasahayam Jesudas
    Dandona, Lalit
    Dandona, Rakhi
    Dharmaratne, Samath D.
    Huyen Phuc Do
    Fischer, Florian
    Geleto, Ayele
    Ghoshal, Aloke Gopal
    Gillum, Richard F.
    Ginawi, Ibrahim Abdelmageem Mohamed
    Gupta, Vipin
    Hay, Simon I.
    Hedayati, Mohammad T.
    Horita, Nobuyuki
    Hosgood, H. Dean
    Jakovljevic, Mihajlo B.
    James, Spencer Lewis
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (09) : 691 - 706
  • [58] Measuring the success of treatment for chronic obstructive pulmonary disease - patient, physician and healthcare payer perspectives
    Van Der Molen, T
    Pieters, W
    Bellamy, D
    Taylor, R
    [J]. RESPIRATORY MEDICINE, 2002, 96 : S17 - S21
  • [59] Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
    Wedzicha, Jadwiga A.
    Decramer, Marc
    Ficker, Joachim H.
    Niewoehner, Dennis E.
    Sandstrom, Thomas
    Taylor, Angel Fowler
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    [J]. LANCET RESPIRATORY MEDICINE, 2013, 1 (03) : 199 - 209
  • [60] The role of tuberculosis in COPD
    Yakar, Halil Ibrahim
    Gunen, Hakan
    Pehlivan, Erkan
    Aydogan, Selma
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 323 - 329